Fulgent Genetics (FLGT) Short-term Investments (2016 - 2026)

Fulgent Genetics has disclosed Short-term Investments across 11 years of filings, most recently posting $230.7 million for Q2 2026.

• In Q2 2026, Short-term Investments rose 12.52% year-over-year to $230.7 million; the TTM figure through Jun 2026 stood at $230.7 million (up 12.52% YoY), while the FY2025 annual figure was $285.9 million, up 40.86% from the prior year.
• Short-term Investments came in at $230.7 million for Q2 2026 at Fulgent Genetics, down from $252.9 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $446.7 million in Q4 2022 to a low of $155.0 million in Q3 2024.
• Average Short-term Investments over 5 years is $297.1 million, with a median of $255.6 million recorded in 2025.
• Year-over-year, Short-term Investments surged 88.89% in 2023 and sank 59.6% in 2024.
• Over 5 years, Short-term Investments stood at $446.7 million in 2022, then decreased by 26.87% to $326.7 million in 2023, then tumbled by 37.87% to $203.0 million in 2024, then jumped by 40.86% to $285.9 million in 2025, then decreased by 19.29% to $230.7 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $230.7 million in Q2 2026, $252.9 million in Q1 2026, and $285.9 million in Q4 2025.